Inpixon Stock Forecast: Think of all the rooms and touchpoints in your place of business. Doorknobs, countertops, keyboards, touchscreens. Even the air in each room.
Coronavirus has everyone thinking of things they never really thought of before.
In today’s COVID-19 world, what if you had access to a tool that could help make your workplace, school, or other business safer?
Inpixon = Indoor Intelligence
Inpixon specializes in indoor intelligence. Indoor intelligence is basically a method of capturing, understanding, and providing context regarding indoor data that can be then transferred into actionable information.
The Inpixon platform takes information from inside your location – from things like the IoT, cellular data, Wi-Fi connections, and Bluetooth devices, among others. It does so using Inpixon’s proprietary processes and ensures anonymity and data privacy.
When paired to its data analyzing engine and mapping tech, the information gleaned helps a variety of industries make use of the information.
With said info, companies and organizations can increase their revenue, lower costs, and, above all, enhance their safety protocols.
In light of COVID-19, the information provided by Inpixon’s indoor intelligence could prove quite beneficial.
Is Inpixon Stock A Buy?
Towards the end of the first half of the year, Inpixon’s shares saw an immediate jump after the CEO reported that Inpixon is now working alongside hotels and cruise providers on providing contact tracing capabilities.
Nadir Ali, CEO of Inpixon, reported his company would be able to collect data via scanners that can home in on cellphone, Bluetooth, and Wi-Fi signals.
This could alert cruise lines and hotels of things such as:
- Too many people congregating in one area
- Passengers or guests in close proximity with others
- Create a record of illness once reported and be able to alert guests if they’ve been exposed
Inpixon’s proprietary radio-frequency ID (RFID) technology lets the data do the talking – but some are skeptical. What about privacy issues?
Ali states that the RFID, while it allows data intelligence, is entirely encrypted, anonymous, and poses no security issues. However, in the case of an emergency, such as an outbreak aboard a cruise liner, this data can be used to isolate those who are sick or showing symptoms.
As for if the stock is a buy, after this announcement the stock temporarily gained 8.4% over the course of the day on Monday – but even this gain is miniscule when compared to its drop of over 70% since the beginning of the year.
That said, Inpixon believes its service can fill a crucial need during this pandemic. Could that boost the stock over time? That remains to be seen.
Risks of Investing In Inpixon
When analyzing a volatile stock like Inpixon, it’s important to consider the company’s balance sheet.
The fundamental health of a company is determined by its ability to take care of not just its financial obligations, but also non-financial obligations.
If a company fares well in this respect, they’ll keep their shareholders’ faith. But, unfortunately for Inpixon, its balance sheet reflects $6.11 million in cashflow and $9.66 million in liabilities. It will take analyzing this stock over the long-term to see if this is a viable investment option.
Analysts agree that Inpixon is certainly interesting. But they also warn that prior to any investment decision, you should look at its trading activities in-depth.
The company could capitalize on catalysts and attempt to avoid obstacles – but everything facing this company at present is due to its operations.
Analyzing current events, such as the COVID-19 pandemic, and the company’s current outlook can help paint a better, broader picture of what could actually be in store for Inpixon stock.
From a technical perspective, the company’s weekly volatility rating is 18.04%. Over the past 52 weeks, this stock has seen a high of $42.71 and a low of $1.01. That could suggest Wall Street has largely abandoned the company as a hopeful prospect.
Will Inpixon Competitors Beat It?
Inpixon’s greatest rival is Ekahau. This telecommunications company generates over $10.8 million more in annual revenue than Inpixon. Ekahau is a currently a privately held company. Analysts anxiously await their IPO.
Inpixon’s next closest rival is Sonitor, a healthcare technology company.
Sonitor recorded $2.8 million more in annual revenue than Inpixon. Sonitor is also a privately held company. No word to date on when their IPO could happen.
Inpixon Stock Forecast: The Bottom Line
If you already hold shares of Inpixon, you’re probably wondering if you should sell or continue to hold.
Over the past year, Inpixon has lagged behind what analysts thought could be a booming year for the company.
If you’re holding onto this stock because you believe in the growth potential of the company, there are several other tech stocks that have shown much better growth over the past year – some of which are actually trading lower than industry average.
Think about how this company fits in your overall portfolio and what it could cost you to hold onto it.
If you haven’t bought into Inpixon just yet but you’ve been watching it for some time, it might be a good idea to dig a bit deeper and do some thorough research into the company’s past – how they handle their funding among other things.
While Inpixon certainly hasn’t delivered the numbers of its closest rivals, it could be just that the market is pessimistic right now. This could mean that Inpixon stock is currently undervalued.
Before deciding if Inpixon stock is a buy for you, research their current and future cashflow to determine if this stock is trading reasonably.
The bottom line is Inpixon might not be the right stock to buy at this time – but all investments are a personal decision.
The author has no position in any of the stocks mentioned. Financhill has a disclosure policy. This post may contain affiliate links or links from our sponsors.